Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL E MAY

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1629160056
CMS profile
409450
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$109.49

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $109.49 1

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
LIFESCAN, INC. $109.49 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL E MAY

NPI 1629160056 · CMS profile ID 409450

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629160056?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL E MAY, NPI 1629160056, CMS profile ID 409450. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629160056?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MICHAEL E MAY, NPI 1629160056, CMS profile ID 409450. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629160056?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MICHAEL E MAY, NPI 1629160056, CMS profile ID 409450, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1629160056?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $109.49 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
LIFESCAN, INC. $109.4906/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 919446117 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $186.35 1
PY2022 $109.49 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2022
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $26,117.22 38
PY2023 Principal investigator $126,418.70 386
PY2022 Principal investigator $130,387.99 373
PY2021 Principal investigator $210,789.66 774
PY2020 Principal investigator $138,773.01 309
PY2019 Principal investigator $55,793.27 49

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

774 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621749
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622077
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622087
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622231
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622241
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622251
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622261
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622271
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622283
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622293
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622303
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773343
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773345
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773347
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773609
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773611
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773677
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773679
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869105
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869107
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869109
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869111
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869147
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869149
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869181
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869183
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869185
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869187
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869189
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869191
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869193
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891971
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891973
Principal investigator 1 Novo Nordisk AS $220.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892023
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892049
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892051
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892053
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892055
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892057
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892059
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892061
Principal investigator 1 Novo Nordisk AS $19.96 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892063
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892065
Principal investigator 1 Novo Nordisk AS $20.00 12/29/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892067
Principal investigator 1 Novo Nordisk AS $793.12 12/22/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225451
Principal investigator 1 Novo Nordisk AS $7,385.96 12/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773681
Principal investigator 1 Novo Nordisk AS $933.16 12/22/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856235
Principal investigator 1 Novo Nordisk AS $5,074.29 12/22/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858307
Principal investigator 1 Novo Nordisk AS $25.06 12/16/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811832325
Principal investigator 1 Novo Nordisk AS $2.97 12/16/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856233
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247801
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247811
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248007
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248017
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544935
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544945
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544955
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544965
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834455
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834463
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834465
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834467
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858299
Principal investigator 1 Novo Nordisk AS $60.00 12/15/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858303
Principal investigator 1 Novo Nordisk AS $7,189.97 12/01/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773683
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621703
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621713
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621723
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621731
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621739
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621999
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622009
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622019
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622029
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622039
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622049
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622059
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622069
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623431
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623605
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623613
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623623
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623633
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623643
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623653
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623663
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623673
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623683
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623693
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773335
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773337
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773339
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773341
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773595
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773597
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773599
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773601
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773603
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773605
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773607
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773829
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773831
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773833
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773851
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773853
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773855
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773857
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773859
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773861
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773863
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773865
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773867
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869095
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869097
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869099
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869101
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869103
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869141
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869143
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869145
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869283
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869285
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869287
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869289
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869291
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869293
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869295
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869297
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891963
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891965
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891967
Principal investigator 1 Novo Nordisk AS $240.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891969
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892017
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892019
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892021
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892151
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892153
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892155
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892157
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892159
Principal investigator 1 Novo Nordisk AS $19.96 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892161
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892163
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892165
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892167
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892169
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892171
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892173
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892175
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892177
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892179
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892181
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892183
Principal investigator 1 Novo Nordisk AS $13.00 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892185
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892187
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892189
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892191
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892193
Principal investigator 1 Novo Nordisk AS $7.60 11/24/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892195
Principal investigator 1 Novo Nordisk AS $2,310.00 11/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 833635745
Principal investigator 1 Novo Nordisk AS $2,310.00 11/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 833635747
Principal investigator 1 Novo Nordisk AS $1,808.00 11/05/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622601
Principal investigator 1 Novo Nordisk AS $658.80 11/05/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869231
Principal investigator 1 Novo Nordisk AS $9.00 10/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225421
Principal investigator 1 Novo Nordisk AS $5.94 10/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856231
Principal investigator 1 Novo Nordisk AS $1,178.19 10/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858305
Principal investigator 1 Novo Nordisk AS $5,000.00 10/27/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892069
Principal investigator 1 Novo Nordisk AS $1,500.00 10/27/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892071
Principal investigator 1 Novo Nordisk AS $24,204.12 10/27/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892073
Principal investigator 1 Novo Nordisk AS $9.99 10/22/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811832323
Principal investigator 1 Novo Nordisk AS $23.06 10/22/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856229
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247765
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247773
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247783
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247793
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247821
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248027
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248113
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248123
Principal investigator 1 Novo Nordisk AS $19.75 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248141
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248149
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248157
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545025
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545035
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545045
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545055
Principal investigator 1 Novo Nordisk AS $79.05 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545065
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545201
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834445
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834447
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834449
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834451
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834453
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834457
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834459
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834461
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834477
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834479
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834481
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834497
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834499
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834501
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858287
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858289
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858291
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858293
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858295
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858297
Principal investigator 1 Novo Nordisk AS $648.00 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858301
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858311
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858313
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858315
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858331
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858333
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858335
Principal investigator 1 Novo Nordisk AS $7.50 10/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858337
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621912
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621921
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621971
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621979
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621989
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622343
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622373
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622381
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622389
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622563
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622573
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622581
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622591
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773589
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773593
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773691
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773693
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773695
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773697
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773699
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773701
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773703
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869135
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869137
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869195
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869201
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869203
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869205
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869207
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869209
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869211
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869213
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869215
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869217
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869219
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869221
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869223
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869225
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869227
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869229
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891997
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891999
Principal investigator 1 Novo Nordisk AS $200.00 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892011
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892013
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892015
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892075
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892081
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892083
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892085
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892087
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892089
Principal investigator 1 Novo Nordisk AS $19.96 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892091
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892093
Principal investigator 1 Novo Nordisk AS $7.60 10/15/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892095
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621893
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621903
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622213
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622223
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622313
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622323
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622333
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622353
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622363
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773587
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773675
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773685
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773687
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773689
Principal investigator 1 Novo Nordisk AS $1.65 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773825
Principal investigator 1 Novo Nordisk AS $1.65 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773827
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869131
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869133
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869175
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869177
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869179
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869197
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869199
Principal investigator 1 Novo Nordisk AS $1.65 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869277
Principal investigator 1 Novo Nordisk AS $1.65 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869279
Principal investigator 1 Novo Nordisk AS $1.65 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869281
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891993
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891995
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892047
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892077
Principal investigator 1 Novo Nordisk AS $24.95 10/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892079
Principal investigator 1 Novo Nordisk AS $2,758.86 09/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834469
Principal investigator 1 Novo Nordisk AS $661.50 09/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225431
Principal investigator 1 Novo Nordisk AS $523.32 09/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225441
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621807
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622117
Principal investigator 1 Novo Nordisk AS $3.30 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622127
Principal investigator 1 Novo Nordisk AS $3.30 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622137
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622145
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623741
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623751
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623761
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623771
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623953
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623963
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623973
Principal investigator 1 Novo Nordisk AS $3.30 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773351
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773353
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773355
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773357
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773661
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773663
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773877
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773879
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773881
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773883
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773885
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773995
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773997
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773999
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774001
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774003
Principal investigator 1 Novo Nordisk AS $3.30 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869115
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869117
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869119
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869157
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869159
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869161
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869319
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869321
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869323
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869325
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869327
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869329
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869331
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869333
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869335
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891975
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891977
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891979
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891981
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891983
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892029
Principal investigator 1 Novo Nordisk AS $12.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892031
Principal investigator 1 Novo Nordisk AS $3.30 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892033
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892035
Principal investigator 1 Novo Nordisk AS $200.00 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892037
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892205
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892207
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892209
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892211
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892213
Principal investigator 1 Novo Nordisk AS $17.07 09/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892215
Principal investigator 1 Novo Nordisk AS $660.00 09/07/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891987
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621865
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621875
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621883
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622183
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622193
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622203
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623287
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623297
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623307
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623315
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623325
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623335
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623345
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623355
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623365
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623375
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623383
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623391
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623401
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623411
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623421
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773585
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773673
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773803
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773807
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773809
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773811
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773813
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773815
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773817
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773819
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773821
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773823
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869129
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869171
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869173
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869249
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869251
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869253
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869255
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869257
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869259
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869261
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869263
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869265
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869267
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869269
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869271
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869273
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869275
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891989
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891991
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892045
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892133
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892135
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892137
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892139
Principal investigator 1 Novo Nordisk AS $17.07 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892141
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892143
Principal investigator 1 Novo Nordisk AS $5.70 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892145
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892147
Principal investigator 1 Novo Nordisk AS $60.00 08/26/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892149
Principal investigator 1 Novo Nordisk AS $2,182.63 08/25/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834443
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247737
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247745
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248077
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248087
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248093
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248103
Principal investigator 1 Novo Nordisk AS $18.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544917
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545141
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545151
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545161
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545171
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545181
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545191
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834491
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834493
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834495
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858285
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858323
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858325
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858327
Principal investigator 1 Novo Nordisk AS $216.00 08/19/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858329
Principal investigator 1 Novo Nordisk AS $904.00 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623701
Principal investigator 1 Novo Nordisk AS $39.90 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623711
Principal investigator 1 Novo Nordisk AS $9.74 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623721
Principal investigator 1 Novo Nordisk AS $40.00 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623731
Principal investigator 1 Novo Nordisk AS $11.72 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773873
Principal investigator 1 Novo Nordisk AS $0.50 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773875
Principal investigator 1 Novo Nordisk AS $5.94 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869299
Principal investigator 1 Novo Nordisk AS $439.20 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869301
Principal investigator 1 Novo Nordisk AS $5.30 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869303
Principal investigator 1 Novo Nordisk AS $3.04 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869305
Principal investigator 1 Novo Nordisk AS $8.00 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869317
Principal investigator 1 Novo Nordisk AS $0.20 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892197
Principal investigator 1 Novo Nordisk AS $325.80 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892199
Principal investigator 1 Novo Nordisk AS $6.50 08/17/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892203
Principal investigator 1 Novo Nordisk AS $0.10 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621759
Principal investigator 1 Novo Nordisk AS $2.97 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621769
Principal investigator 1 Novo Nordisk AS $452.00 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621779
Principal investigator 1 Novo Nordisk AS $219.60 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621789
Principal investigator 1 Novo Nordisk AS $2.65 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621799
Principal investigator 1 Novo Nordisk AS $162.90 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773349
Principal investigator 1 Novo Nordisk AS $4.00 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773869
Principal investigator 1 Novo Nordisk AS $20.00 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773871
Principal investigator 1 Novo Nordisk AS $5.86 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869307
Principal investigator 1 Novo Nordisk AS $0.25 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869309
Principal investigator 1 Novo Nordisk AS $19.95 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869311
Principal investigator 1 Novo Nordisk AS $3.25 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869313
Principal investigator 1 Novo Nordisk AS $4.87 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869315
Principal investigator 1 Novo Nordisk AS $1.52 08/11/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892201
Principal investigator 1 Novo Nordisk AS $6.99 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773657
Principal investigator 1 Novo Nordisk AS $1.65 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773659
Principal investigator 1 Novo Nordisk AS $1.65 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869113
Principal investigator 1 Novo Nordisk AS $6.99 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869153
Principal investigator 1 Novo Nordisk AS $1.65 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869155
Principal investigator 1 Novo Nordisk AS $1.65 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811870215
Principal investigator 1 Novo Nordisk AS $1.65 08/03/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892027
Principal investigator 1 Novo Nordisk AS $1,566.04 07/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834441
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621951
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621961
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622097
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622107
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624039
Principal investigator 1 Novo Nordisk AS $3.30 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624049
Principal investigator 1 Novo Nordisk AS $3.30 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624059
Principal investigator 1 Novo Nordisk AS $3.30 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624069
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773591
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773613
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773615
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773617
Principal investigator 1 Novo Nordisk AS $0.25 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773655
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774017
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774019
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774021
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774023
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774025
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774027
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774029
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774037
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774039
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774041
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774043
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869139
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869151
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869361
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869363
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869365
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869367
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869369
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869371
Principal investigator 1 Novo Nordisk AS $3.30 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869373
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892005
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892007
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892009
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892025
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892219
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892221
Principal investigator 1 Novo Nordisk AS $80.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892223
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892225
Principal investigator 1 Novo Nordisk AS $9.98 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892227
Principal investigator 1 Novo Nordisk AS $4.00 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892229
Principal investigator 1 Novo Nordisk AS $3.30 07/22/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892231
Principal investigator 1 Novo Nordisk AS $13.98 07/21/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624031
Principal investigator 1 Novo Nordisk AS $13.98 07/21/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869359
Principal investigator 1 Novo Nordisk AS $3,297.06 06/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545631
Principal investigator 1 Novo Nordisk AS $1,791.00 06/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856251
Principal investigator 1 Novo Nordisk AS $2,265.98 06/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856253
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248037
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248047
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248057
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811248067
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544907
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545075
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545085
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545095
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545105
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545111
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545121
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545131
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834483
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834485
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834487
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834489
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858317
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858319
Principal investigator 1 Novo Nordisk AS $1,008.00 06/21/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858321
Principal investigator 1 Novo Nordisk AS $562.00 06/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624022
Principal investigator 1 Novo Nordisk AS $394.00 06/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774015
Principal investigator 1 Novo Nordisk AS $5.98 06/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869357
Principal investigator 1 Novo Nordisk AS $19.00 06/08/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892217
Principal investigator 1 Novo Nordisk AS $1,332.83 05/26/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811519611
Principal investigator 1 Novo Nordisk AS $997.87 05/26/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856249
Principal investigator 1 Novo Nordisk AS $2,020.59 05/26/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858407
Principal investigator 1 Novo Nordisk AS $19.00 05/20/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621931
Principal investigator 1 Novo Nordisk AS $5.98 05/20/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892001
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621941
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623983
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623993
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624003
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811624013
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774005
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774007
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774009
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774011
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811774013
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869337
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869339
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869341
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869343
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869345
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869347
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869349
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869351
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869353
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869355
Principal investigator 1 Novo Nordisk AS $9.98 05/19/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892003
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621815
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621825
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621835
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621845
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811621855
Principal investigator 1 Novo Nordisk AS $5.94 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622155
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622163
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622173
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622727
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623267
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811623277
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773359
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773361
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773363
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773583
Principal investigator 1 Novo Nordisk AS $0.20 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773667
Principal investigator 1 Novo Nordisk AS $904.00 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773669
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773671
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773713
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773715
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773717
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773719
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773721
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773723
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773725
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773799
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773801
Principal investigator 1 Novo Nordisk AS $439.20 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869121
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869123
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869125
Principal investigator 1 Novo Nordisk AS $1.95 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869127
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869167
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869169
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869237
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869239
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869241
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869243
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869245
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869247
Principal investigator 1 Novo Nordisk AS $325.80 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892039
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892041
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892043
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892115
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892117
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892119
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892121
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892123
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892125
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892127
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892129
Principal investigator 1 Novo Nordisk AS $3.05 05/13/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892131
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622611
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622623
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622633
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622643
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622649
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622659
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622669
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622679
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622689
Principal investigator 1 Novo Nordisk AS $5.30 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622699
Principal investigator 1 Novo Nordisk AS $11.72 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622709
Principal investigator 1 Novo Nordisk AS $39.90 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811622717
Principal investigator 1 Novo Nordisk AS $6.50 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773665
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773705
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773707
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773709
Principal investigator 1 Novo Nordisk AS $0.50 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773711
Principal investigator 1 Novo Nordisk AS $9.74 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869163
Principal investigator 1 Novo Nordisk AS $40.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869165
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869233
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811869235
Principal investigator 1 Novo Nordisk AS $3.01 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811891985
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892097
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892099
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892101
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892103
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892105
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892107
Principal investigator 1 Novo Nordisk AS $3.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892109
Principal investigator 1 Novo Nordisk AS $3.04 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892111
Principal investigator 1 Novo Nordisk AS $8.00 05/06/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811892113
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247667
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247677
Principal investigator 1 Novo Nordisk AS $126.48 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544657
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544667
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544869
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544879
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544887
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544897
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544975
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544985
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544995
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545005
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545015
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834471
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834473
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834475
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858277
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858283
Principal investigator 1 Novo Nordisk AS $756.00 04/27/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858309
Principal investigator 1 Novo Nordisk AS $46.12 04/26/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225411
Principal investigator 1 Novo Nordisk AS $3,215.73 04/25/2021 Non-covered Recipient Entity
VANDERBILT DIABETES AND OBESITY CLINICAL TRIALS CE
NN1436-4480 No dispute reported 06/30/2026 811773805
Principal investigator 1 Novo Nordisk AS $997.87 04/23/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225509
Principal investigator 1 Novo Nordisk AS $5,865.79 04/23/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811545211
Principal investigator 1 Novo Nordisk AS $1,332.83 04/23/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811832331
Principal investigator 1 Novo Nordisk AS $69.18 04/20/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811225215
Principal investigator 1 Novo Nordisk AS $6,226.74 03/29/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544925
Principal investigator 1 Novo Nordisk AS $762.75 03/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811250009
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811519581
Principal investigator 1 Novo Nordisk AS $523.32 03/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811546135
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856237
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247439
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247449
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247457
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247466
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247475
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247485
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247495
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247707
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247717
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247727
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544567
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544577
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544587
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544597
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544607
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544617
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544627
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544637
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544647
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834417
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834419
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834421
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834423
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834425
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834427
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834429
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834431
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834433
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834437
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834439
Principal investigator 1 Novo Nordisk AS $75.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858251
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858253
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858255
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858257
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858259
Principal investigator 1 Novo Nordisk AS $360.00 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858261
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858263
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858265
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858267
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858269
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858271
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858273
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858275
Principal investigator 1 Novo Nordisk AS $6.72 03/11/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858281
Principal investigator 1 Novo Nordisk AS $70.86 03/08/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811832319
Principal investigator 1 Novo Nordisk AS $4.50 03/08/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811856225
Principal investigator 1 Novo Nordisk AS $69.18 03/02/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811519591
Principal investigator 1 Novo Nordisk AS $130.00 02/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811360251
Principal investigator 1 Novo Nordisk AS $5,239.84 02/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811360259
Principal investigator 1 Novo Nordisk AS $250.00 02/24/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811841029
Principal investigator 1 Novo Nordisk AS $631.12 02/22/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811546125
Principal investigator 1 Novo Nordisk AS $4.50 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247389
Principal investigator 1 Novo Nordisk AS $4.50 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247399
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247409
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247419
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247429
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247687
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247697
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811247755
Principal investigator 1 Novo Nordisk AS $30.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544549
Principal investigator 1 Novo Nordisk AS $18.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544557
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544849
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811544859
Principal investigator 1 Novo Nordisk AS $0.56 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834403
Principal investigator 1 Novo Nordisk AS $3.25 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834405
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834407
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834409
Principal investigator 1 Novo Nordisk AS $16.04 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834411
Principal investigator 1 Novo Nordisk AS $45.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834413
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834415
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811834435
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858243
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858245
Principal investigator 1 Novo Nordisk AS $2.65 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858247
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858249
Principal investigator 1 Novo Nordisk AS $180.00 02/03/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811858279
Principal investigator 1 Novo Nordisk AS $631.12 01/28/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
NN9535-4352 No dispute reported 06/30/2026 811834661
Principal investigator 1 Novo Nordisk AS $5,529.42 01/26/2021 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
EX9924-4473 No dispute reported 06/30/2026 811360221
Principal investigator 1 SANOFI US SERVICES INC. $12,802.33 01/20/2021 Non-covered Recipient Entity
Vanderbilt University Childrens Diabetes Program
Epidemiology of Diabetes Interventions and Complications No dispute reported 06/30/2026 838668263
Principal investigator 1 SANOFI US SERVICES INC. $3,930.53 01/20/2021 Non-covered Recipient Entity
Vanderbilt University Childrens Diabetes Program
Epidemiology of Diabetes Interventions and Complications No dispute reported 06/30/2026 838668265
Principal investigator 1 SANOFI US SERVICES INC. $1,138.24 01/20/2021 Non-covered Recipient Entity
Vanderbilt University Childrens Diabetes Program
Epidemiology of Diabetes Interventions and Complications No dispute reported 06/30/2026 838668269